About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Nashville | 359 Studies

Clinical Trials Colorectal CancerNashville

Colorectal Cancer Clinical Trials in Nashville

Find 359 clinical trials for colorectal cancer near Nashville, Tennessee. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Nashville

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 201-220 of 359 trials

CompletedOxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal CancerRATIONALE: Drugs used in chemotherapy, such as oxaliplatin, fluorouracil, leucovorin, and capecitabine, work in different ways to stop tumor cells from dividing so they stop…NCT00062426·Birmingham, Alabama and 51 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Study of a Personalized Cancer Vaccine Targeting Shared NeoantigensThe purpose of this study is to evaluate the dose, safety, immunogenicity and early clinical activity of GRT-C903 and GRT-R904, a neoantigen-based therapeutic cancer vaccine, in…NCT03953235·Phoenix, Arizona and 11 others

Active not recruiting9-ING-41 in Patients With Advanced CancersGSK-3β is a potentially important therapeutic target in human malignancies.NCT03678883·Phoenix, Arizona and 65 others

CompletedMagnesium Treatment on Vitamin D Metabolism in Participants Completed Personalized Prevention of Colorectal Cancer TrialOne striking observation is that a large portion of the inter-person variation in serum 25-hydroxyvitamin D (25(OH)D) levels is unexplained.NCT03265483·Nashville, Tennessee

TerminatedStudy of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal CancerOpen-label phase 1b trial. Study treatment will be administered in 3 week cycles.NCT00719199·Washington D.C., District of Columbia and 4 others

Active not recruitingDose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of escalating doses of RMC-6291 (KRAS G12C(ON) inhibitor) monotherapy in adult…NCT05462717·Springdale, Arkansas and 63 others

RecruitingTesting the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and EffectivenessThis phase I/II trial studies the side effects and best dose of temozolomide and M1774 and how well they works in treating patients with cancer that has spread from where it first…NCT05691491·Irvine, California and 22 others

Active not recruitingStudy of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or LymphomasThis is a Phase 1/2a open-label, multicenter, dose escalation and dose expansion trial in which IMT-009 will be administered by the intravenous (IV) route to participants with…NCT05565417·Tucson, Arizona and 8 others

TerminatedA Safety Study of SGN-CD47M in Patients With Solid TumorsThis trial will study SGN-CD47M to find out whether it is an effective treatment for different types of solid tumors and what side effects (unwanted effects) may occur.NCT03957096·Cleveland, Ohio and 4 others

CompletedA Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid TumorsThe Phase 1b part of this study is conducted to assess the safety and tolerability of E7386 in combination with pembrolizumab in participants with previously treated selected…NCT05091346·Los Angeles, California and 31 others

CompletedStudy of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer IndicationsThis is a first-in-human, multi-center, open-label clinical study with separate dose escalation (Phase 1) and expansion (Phase 2) stages to assess preliminary safety…NCT02649790·Los Angeles, California and 45 others

CompletedBRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC)This was a four part, phase I/II study aimed to evaluate the safety, tolerability and efficacy of combination of an anti-EGFR antibody panitumumab (P) either with a BRAF inhibitor…NCT01750918·Scottsdale, Arizona and 19 others

RecruitingA Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)This study aims to address the unmet medical need of participants with metastatic colorectal cancer (mCRC) who have previously been treated with irinotecan, oxaliplatin, a…NCT07549412·San Francisco, California and 115 others

CompletedA Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal CancerThis is a Phase 1 study currently evaluating PO administered ompenaclid in combination with FOLFIRI and bevacizumab in patients with advanced (i.e., locally advanced and…NCT03597581·Prescott Valley, Arizona and 16 others

TerminatedStudy of IK-595 in RAS- or RAF-altered Advanced TumorsThis is a Phase 1, FIH, Dose Escalation and Dose Expansion study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) effects, and preliminary…NCT06270082·Duarte, California and 14 others

TerminatedPF-06952229 Treatment in Adult Patients With Advanced Solid TumorsA Phase 1 dose escalation and expansion study evaluating safety, tolerability and pharmacokinetics of PF-06952229 in adult patients with advanced solid tumors.NCT03685591·Scottsdale, Arizona and 14 others

TerminatedPhase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed CancersThis study is a first-in-human, Phase 1a/1b, multicenter, open-label study to determine the safety, tolerability, and pharmacokinetics of aplitabart as a single agent and in…NCT04553692·Phoenix, Arizona and 57 others

CompletedA Study of Ramucirumab or Icrucumab in Colorectal CancerThe purpose of this study is to determine if participants with metastatic colorectal cancer live longer without their cancer progressing when treated with standard chemotherapy…NCT01111604·Cincinnati, Ohio and 16 others

RecruitingA Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal CancerThis study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer.NCT05253651·Glendale, Arizona and 365 others

RecruitingA Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyThe purpose of this study is to compare how long the participants are disease-free (progression-free survival) and and the length of time until a participant dies (overall…NCT06750094·Chandler, Arizona and 250 others

PreviousPage 11 of 18Next

Other Conditions in Nashville

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma